| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 71.62B | 60.15B | 50.27B | 42.52B | 30.12B | 30.88B |
| Gross Profit | 62.05B | 50.17B | 30.04B | 27.70B | 18.37B | 15.59B |
| EBITDA | 51.80B | 42.01B | 21.64B | 16.00B | 12.70B | 10.59B |
| Net Income | 9.36B | 10.38B | 8.03B | 5.97B | 5.17B | 3.97B |
Balance Sheet | ||||||
| Total Assets | 15.06T | 13.77T | 13.74T | 14.06T | 14.17T | 12.14T |
| Cash, Cash Equivalents and Short-Term Investments | 6.04T | 5.85T | 1.98T | 1.67T | 1.41T | 1.42T |
| Total Debt | 12.37T | 10.97T | 3.75T | 8.62T | 9.17T | 7.80T |
| Total Liabilities | 14.93T | 13.64T | 13.60T | 13.92T | 14.03T | 12.00T |
| Stockholders Equity | 131.80B | 134.35B | 144.61B | 135.73B | 138.00B | 135.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -517.57B | 383.27B | 302.91B | -123.10B | 163.87B |
| Operating Cash Flow | 0.00 | -517.48B | 383.41B | 303.55B | -122.30B | 164.46B |
| Investing Cash Flow | 0.00 | 1.75B | 4.58B | 3.45B | 4.91B | 2.23B |
| Financing Cash Flow | 0.00 | -672.60B | -6.62B | -5.79B | -5.09B | -2.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥404.58B | 8.49 | ― | 3.65% | 21.22% | -2.77% | |
72 Outperform | ¥173.50B | 13.86 | 6.77% | 3.66% | 54.96% | -0.61% | |
72 Outperform | ¥2.08T | 10.19 | 8.92% | 3.20% | 3.42% | 22.06% | |
71 Outperform | ¥5.01T | 10.66 | 10.32% | 3.30% | 6.21% | 11.62% | |
69 Neutral | ¥441.24B | 16.35 | 14.42% | 4.80% | 10.39% | 12.77% | |
68 Neutral | ¥189.57B | 11.64 | ― | 3.30% | 7.36% | -3.80% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |